The report will be delivered in 2-3 business days.

Central Nervous System Drugs Global Market Report 2020-30: Covid 19 Implications and Growth

Starting Price : $ 4000.00 $3200.00 | Pages : 150 | Published : May 2020 | SKU CODE : 8385 | Format :


The central nervous system drugs market consists sales of central nervous system drugs and related services by entities (organizations, sole traders and partnerships) that produce central nervous system drugs to treat brain and spinal cord diseases. This industry includes establishments that produce nervous system drugs, pain reducing analgesics, anti-Parkinson drugs to treat Parkinson’s disease, anticonvulsant anti-epileptics drugs to control epileptic seizures, anesthetics and other drugs such as muscle relaxants, antiemetics.

The global central nervous system drugs market is expected to grow from $123.4 billion in 2019 to $136.7 billion in 2020 at a compound annual growth rate (CAGR) of 10.8%. This growth is mainly due to the COVID-19 outbreak and the neuroinvasive nature of the virus. The CNS is more prone to the viral infection. The virus affects the senses of smell and taste and therefore it is important to curb the interaction between the viral protein and the human receptor, and this factor is driving the demand for CNS drugs. The market is then expected to recover and grow at a CAGR of 6% from 2021 and reach $160.4 billion in 2023.

North America was the largest region in the global central nervous system drugs market, accounting for 48% of the market in 2019. Asia Pacific was the second largest region accounting for 22% of the global central nervous system drugs market. Africa was the smallest region in the global central nervous system drugs market.

Pharmaceutical companies are partnering with technology companies and incorporating wearables in clinical studies and for  research and development of CNS disease treatments. These wearable devices make use of sensors to detect early symptoms of Parkinson’s disease such as tremors, slowness and stiffness in patients. Researchers use this data to gain insights about the disease and potential drug reactions, and thus reduce the time for trials by 30% to 50%. For instance, in 2017, Michael J. Fox Foundation for Parkinson’s Research collaborated with specialty drug maker Cynapsus Therapeutics and Intel to integrate wearable technology in a Phase-III clinical trial of APL-130277, an experimental drug for Parkinson’s disease. Biogen, a leading CNS drug maker is using Fitbit, a smart wearable tracker, to better understand multiple sclerosis in patient studies, and the technology is expected to extend in Alzheimer’s disease research.

The major players in the global central nervous system drugs market are Biogen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Pfizer Inc, Novartis AG

The countries covered in the global central nervous system drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

The Global Central Nervous System Drugs Market is segmented:
1) By Type: Analgesics, Anti-Parkinson drugs, Anesthetics, Anti-Epileptics, Other CNS drugs
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route Of Administration: Oral, Parenteral, Others
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

    1. Executive Summary

    2. Report Structure

    3. Central Nervous System Drugs Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Central Nervous System Drugs Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Central Nervous System Drugs Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Central Nervous System Drugs Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Central Nervous System Drugs Market Trends And Strategies

    8. Central Nervous System Drugs Market Size And Growth

    8.1. Market Size

    8.2. Historic Market Growth, Value ($ Billion)

    8.2.1. Drivers Of The Market

    8.2.2. Restraints On The Market

    8.3. Forecast Market Growth, Value ($ Billion)

    8.3.1. Drivers Of The Market

    8.3.2. Restraints On The Market

    9. Central Nervous System Drugs Market Regional Analysis

    9.1. Global Central Nervous System Drugs Market, 2019, By Region, Value ($ Billion)

    9.2. Global Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region

    9.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

    10. Central Nervous System Drugs Market Segmentation

    10.1. Global Central Nervous System Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Analgesics

    Anti-Parkinson drugs

    Anesthetics

    Anti-Epileptics

    Other CNS drugs

    10.2. Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Others

    10.3. Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Oral

    Parenteral

    Others

    10.4. Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Branded Drugs

    Generic Drugs

    10.5. Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    11. Central Nervous System Drugs Market Metrics

    11.1. Central Nervous System Drugs Market Size, Percentage Of GDP, 2015-2023, Global

    11.2. Per Capita Average Central Nervous System Drugs Market Expenditure, 2015-2023, Global

    12. Asia-Pacific Central Nervous System Drugs Market

    12.1. Asia-Pacific Central Nervous System Drugs Market Overview

    12.2. Asia-Pacific, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)

    12.3. Asia-Pacific, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    12.4. Asia-Pacific, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    12.5. Asia-Pacific, Central Nervous System Drugs Market Metrics

    12.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Asia-Pacific Countries

    12.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Asia-Pacific Countries

    12.6. Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7. Asia-Pacific Central Nervous System Drugs Market: Country Analysis

    12.7.1. China Central Nervous System Drugs Market

    12.7.1.1. China Central Nervous System Drugs Market Overview

    12.7.1.2. China Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.1.3. China Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.2. Australia Central Nervous System Drugs Market

    12.7.2.1. Australia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.2.2. Australia Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.3. Hong Kong Central Nervous System Drugs Market

    12.7.3.1. Hong Kong Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.4. India Central Nervous System Drugs Market

    12.7.4.1. India Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.4.2. India Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.5. Indonesia Central Nervous System Drugs Market

    12.7.5.1. Indonesia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.5.2. Indonesia Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.6. Japan Central Nervous System Drugs Market

    12.7.6.1. Japan Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.6.2. Japan Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.7. Malaysia Central Nervous System Drugs Market

    12.7.7.1. Malaysia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.8. New Zealand Central Nervous System Drugs Market

    12.7.8.1. New Zealand Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.9. Philippines Central Nervous System Drugs Market

    12.7.9.1. Philippines Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.10. Singapore Central Nervous System Drugs Market

    12.7.10.1. Singapore Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.11. South Korea Central Nervous System Drugs Market

    12.7.11.1. South Korea Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.11.2. South Korea Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.12. Thailand Central Nervous System Drugs Market

    12.7.12.1. Thailand Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.13. Vietnam Central Nervous System Drugs Market

    12.7.13.1. Vietnam Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13. Western Europe Central Nervous System Drugs Market

    13.1. Western Europe Central Nervous System Drugs Market Overview

    13.2. Western Europe, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)

    13.3. Western Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    13.4. Western Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    13.5. Western Europe, Central Nervous System Drugs Market Metrics

    13.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Western Europe Countries

    13.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Western Europe Countries

    13.6. Western Europe Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7. Western Europe Central Nervous System Drugs Market: Country Analysis

    13.7.1. Austria Central Nervous System Drugs Market

    13.7.1.1. Austria Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.2. Belgium Central Nervous System Drugs Market

    13.7.2.1. Belgium Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.3. Denmark Central Nervous System Drugs Market

    13.7.3.1. Denmark Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.4. Finland Central Nervous System Drugs Market

    13.7.4.1. Finland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.5. France Central Nervous System Drugs Market

    13.7.5.1. France Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.5.2. France Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.6. Germany Central Nervous System Drugs Market

    13.7.6.1. Germany Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.6.2. Germany Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.7. Ireland Central Nervous System Drugs Market

    13.7.7.1. Ireland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.8. Italy Central Nervous System Drugs Market

    13.7.8.1. Italy Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.9. Netherlands Central Nervous System Drugs Market

    13.7.9.1. Netherlands Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.10. Norway Central Nervous System Drugs Market

    13.7.10.1. Norway Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.11. Portugal Central Nervous System Drugs Market

    13.7.11.1. Portugal Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.12. Spain Central Nervous System Drugs Market

    13.7.12.1. Spain Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.13. Sweden Central Nervous System Drugs Market

    13.7.13.1. Sweden Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.14. Switzerland Central Nervous System Drugs Market

    13.7.14.1. Switzerland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.15. UK Central Nervous System Drugs Market

    13.7.15.1. UK Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.15.2. UK Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14. Eastern Europe Central Nervous System Drugs Market

    14.1. Eastern Europe Central Nervous System Drugs Market Overview

    14.2. Eastern Europe, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)

    14.3. Eastern Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    14.4. Eastern Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    14.5. Eastern Europe, Central Nervous System Drugs Market Metrics

    14.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Eastern Europe Countries

    14.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Eastern Europe Countries

    14.6. Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7. Eastern Europe Central Nervous System Drugs Market: Country Analysis

    14.7.1. Czech Republic Central Nervous System Drugs Market,  

    14.7.1.1. Czech Republic Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.2. Poland Central Nervous System Drugs Market

    14.7.2.1. Poland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.3. Romania Central Nervous System Drugs Market

    14.7.3.1. Romania Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.4. Russia Central Nervous System Drugs Market

    14.7.4.1. Russia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.4.2. Russia Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15. North America Central Nervous System Drugs Market

    15.1. North America Central Nervous System Drugs Market Overview

    15.2. North America, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)

    15.3. North America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    15.4. North America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    15.5. North America, Central Nervous System Drugs Market Metrics

    15.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, North America Countries

    15.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, North America Countries

    15.6. North America Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7. North America Central Nervous System Drugs Market: Country Analysis

    15.7.1. Canada Central Nervous System Drugs Market

    15.7.1.1. Canada Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7.2. Mexico Central Nervous System Drugs Market

    15.7.2.1. Mexico Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7.3. USA Central Nervous System Drugs Market

    15.7.3.1. USA Central Nervous System Drugs Market Overview

    15.7.3.2. USA Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7.3.3. USA Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16. South America Central Nervous System Drugs Market

    16.1. South America Central Nervous System Drugs Market Overview

    16.2. South America, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)

    16.3. South America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    16.4. South America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    16.5. South America, Central Nervous System Drugs Market Metrics

    16.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, South America Countries

    16.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, South America Countries

    16.6. South America Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7. South America Central Nervous System Drugs Market: Country Analysis

    16.7.1. Argentina Central Nervous System Drugs Market

    16.7.1.1. Argentina Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.2. Brazil Central Nervous System Drugs Market

    16.7.1.1. Brazil Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.2.2. Brazil Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.3. Chile Central Nervous System Drugs Market

    16.7.3.1. Chile Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.4. Colombia Central Nervous System Drugs Market

    16.7.4.1. Colombia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.5. Peru Central Nervous System Drugs Market

    16.7.5.1. Peru Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.6. Venezuela Central Nervous System Drugs Market

    16.7.6.1. Venezuela Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17. Middle East Central Nervous System Drugs Market

    17.1. Middle East Central Nervous System Drugs Market Overview

    17.2. Middle East, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)

    17.3. Middle East, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    17.4. Middle East, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    17.5. Middle East, Central Nervous System Drugs Market Metrics

    17.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Middle East Countries

    17.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Middle East Countries

    17.6. Middle East Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7. Middle East Central Nervous System Drugs Market: Country Analysis

    17.7.1. Saudi Arabia Central Nervous System Drugs Market

    17.7.1.1. Saudi Arabia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7.2. Israel Central Nervous System Drugs Market

    17.7.2.1. Israel Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7.3. Turkey Central Nervous System Drugs Market

    17.7.3.1. Turkey Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7.4. UAE Central Nervous System Drugs Market

    17.7.4.1. UAE Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18. Africa Central Nervous System Drugs Market

    18.1. Africa Central Nervous System Drugs Market Overview

    18.2. Africa, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)

    18.3. Africa, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    18.4. Africa, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    18.5. Africa, Central Nervous System Drugs Market Metrics

    18.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Africa Countries

    18.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Africa Countries

    18.6. Africa Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18.7. Africa Central Nervous System Drugs Market: Country Analysis

    18.7.1. Egypt Central Nervous System Drugs Market

    18.7.1.1. Egypt Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18.7.2. Nigeria Central Nervous System Drugs Market

    18.7.2.1. Nigeria Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18.7.3. South Africa Central Nervous System Drugs Market

    18.7.3.1. South Africa Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    19. Central Nervous System Drugs Market Competitive Landscape

    19.1. Competitive Market Overview

    19.2. Market Shares

    19.3. Company Profiles

    19.3.1. Biogen Inc

    19.3.1.1. Company Overview

    19.3.1.2. Products And Services

    19.3.1.3. Strategy

    19.3.1.4. Financial Performance

    19.3.2. F. Hoffmann-La Roche Ltd

    19.3.2.1. Company Overview

    19.3.2.2. Products And Services

    19.3.2.3. Strategy

    19.3.2.4. Financial Performance

    19.3.3. Johnson & Johnson

    19.3.3.1. Company Overview

    19.3.3.2. Products And Services

    19.3.3.3. Strategy

    19.3.3.4. Financial Performance

    19.3.4. Pfizer Inc

    19.3.4.1. Company Overview

    19.3.4.2. Products And Services

    19.3.4.3. Strategy

    19.3.4.4. Financial Performance

    19.3.5. Novartis AG

    19.3.5.1. Company Overview

    19.3.5.2. Products And Services

    19.3.5.3. Strategy

    19.3.5.4. Financial Performance

    20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

    21. Market Background: Pharmaceutical Drugs Market

    21.1. Pharmaceutical Drugs Market Characteristics

    21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global

    21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)

    21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region

    21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

    22. Recommendations

    22.1. Global Central Nervous System Drugs Market In 2023- Growth Countries

    22.2. Global Central Nervous System Drugs Market In 2023- Growth Segments

    22.3. Global Central Nervous System Drugs Market In 2023- Growth Strategies

    23. Appendix

    23.1. NAICS Definitions Of Industry Covered In This Report

    23.2. Abbreviations

    23.3. Currencies

    23.4. Research Inquiries

    23.5. The Business Research Company

    24. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Central Nervous System Drugs Market, 2019, By Region, Value ($ Billion)
  • Table 4: Global Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Table 5: Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Central Nervous System Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: Central Nervous System Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • Table 12: Per Capita Average Central Nervous System Drugs Market Expenditure, 2015-2023, Global
  • Table 13: Asia-Pacific, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 14: Asia-Pacific, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 15: Asia-Pacific, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 16: Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • Table 17: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Asia-Pacific Countries
  • Table 18: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 19: China Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 20: China Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 21: Australia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 22: Australia Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 23: Hong Kong Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 24: India Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 25: India Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 26: Indonesia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 27: Indonesia Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 28: Japan Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 29: Japan Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 30: Malaysia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 31: New Zealand Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 32: Philippines Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 33: Singapore Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 34: South Korea Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 35: Thailand Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 36: Vietnam Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 37: Western Europe, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 38: Western Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 39: Western Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 40: Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Western Europe Countries
  • Table 41: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Western Europe Countries
  • Table 42: Western Europe Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 43: Austria Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 44: Belgium Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 45: Denmark Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 46: Finland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 47: France Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 48: France Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 49: Germany Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 50: Germany Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 51: Ireland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 52: Italy Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 53: Netherlands Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 54: Norway Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 55: Portugal Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 56: Spain Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 57: Sweden Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 58: Switzerland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 59: UK Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 60: UK Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 61: Eastern Europe, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 62: Eastern Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 63: Eastern Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 64: Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • Table 65: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Eastern Europe Countries
  • Table 66: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 67: Czech Republic Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 68: Poland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 69: Romania Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 70: Russia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 71: Russia Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 72: North America, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 73: North America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 74: North America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 75: Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, North America Countries
  • Table 76: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, North America Countries
  • Table 77: North America Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 78: Canada Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 79: Mexico Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 80: USA Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 81: USA Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 82: South America, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 83: South America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 84: South America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 85: Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, South America Countries
  • Table 86: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, South America Countries
  • Table 87: South America Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 88: Argentina Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 89: Brazil Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 90: Brazil Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 91: Chile Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 92: Colombia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 93: Peru Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 94: Venezuela Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 95: Middle East, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 96: Middle East, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 97: Middle East, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 98: Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Middle East Countries
  • Table 99: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Middle East Countries
  • Table 100: Middle East Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 101: Saudi Arabia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 102: Israel Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 103: Turkey Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 104: UAE Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 105: Africa, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 106: Africa, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 107: Africa, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 108: Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Africa Countries
  • Table 109: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Africa Countries
  • Table 110: Africa Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 111: Egypt Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 112: Nigeria Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 113: South Africa Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 114: Biogen Inc Financial Performance
  • Table 115: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 116: Johnson & Johnson Financial Performance
  • Table 117: Pfizer Inc Financial Performance
  • Table 118: Novartis AG Financial Performance
  • Table 119: Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Table 120: Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • Table 121: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Table 122: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Table 123: Global Central Nervous System Drugs Market In 2023- Growth Countries
  • Table 124: Global Central Nervous System Drugs Market In 2023- Growth Segments
  • Table 125: Global Central Nervous System Drugs Market In 2023- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Central Nervous System Drugs Market, 2018, By Region, Value ($ Billion)
  • Figure 4: Global Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • Figure 5: Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Central Nervous System Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 7: Central Nervous System Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • Figure 8: Per Capita Average Central Nervous System Drugs Market Expenditure, 2014 - 2022, Global
  • Figure 9: Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 10: Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 11: Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 12: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
  • Figure 13: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries
  • Figure 14: Asia-Pacific Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 15: China Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 16: China Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 17: China Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 18: Australia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 19: Australia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 20: Australia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 21: Hong Kong Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 22: India Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 23: India Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 24: India Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 25: Indonesia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 26: Japan Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 27: Japan Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 28: Japan Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 29: Malaysia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 30: New Zealand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 31: Philippines Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 32: Singapore Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 33: South Korea Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 34: Thailand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 35: Vietnam Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 36: Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 37: Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 38: Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 39: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Western Europe Countries
  • Figure 40: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries
  • Figure 41: Western Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 42: Austria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 43: Belgium Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 44: Denmark Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 45: Finland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 46: France Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 47: France Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 48: France Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 49: Germany Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 50: Germany Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 51: Germany Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 52: Ireland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 53: Italy Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 54: Italy Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 55: Italy Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 56: Netherlands Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 57: Norway Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 58: Portugal Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 59: Spain Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 60: Spain Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 61: Spain Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 62: Sweden Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 63: Switzerland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 64: UK Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 65: UK Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 66: UK Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 67: Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 68: Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 69: Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 70: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
  • Figure 71: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries
  • Figure 72: Eastern Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 73: Czech Republic Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 74: Poland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 75: Romania Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 76: Russia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 77: Russia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 78: Russia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 79: North America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 80: North America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 81: North America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 82: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, North America Countries
  • Figure 83: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries
  • Figure 84: North America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 85: Canada Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 86: Mexico Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 87: USA Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 88: USA Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 89: USA Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 90: South America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 91: South America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 92: South America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 93: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, South America Countries
  • Figure 94: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries
  • Figure 95: South America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 96: South America Nervous System Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 97: South America Analgesics Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 98: South America Anti-Parkinson drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 99: South America Anesthetics Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 100: South America Anti-Epileptics Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 101: South America Other CNS drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 102: Argentina Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 103: Brazil Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 104: Brazil Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 105: Brazil Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 106: Chile Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 107: Colombia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 108: Peru Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 109: Venezuela Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 110: Middle East, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 111: Middle East, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 112: Middle East, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 113: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Middle East Countries
  • Figure 114: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries
  • Figure 115: Middle East Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 116: Saudi Arabia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 117: Israel Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 118: Turkey Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 119: UAE Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 120: Africa, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 121: Africa, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 122: Africa, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 123: Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Africa Countries
  • Figure 124: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries
  • Figure 125: Africa Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 126: Egypt Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 127: Nigeria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 128: South Africa Central Nervous System Drugs Market2014 - 2022, Value ($ Billion)
  • Figure 129: Biogen Inc Financial Performance
  • Figure 130: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 131: Johnson & Johnson Financial Performance
  • Figure 132: Pfizer Inc Financial Performance
  • Figure 133: Novartis AG Financial Performance
  • Figure 134: Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022, Growth, By Segment, Value ($ Billion), Global
  • Figure 135: Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • Figure 136: Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • Figure 137: Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 138: Global Central Nervous System Drugs Market In 2022- Growth Countries
  • Figure 139: Global Central Nervous System Drugs Market In 2022- Growth Segments
  • Figure 140: Global Central Nervous System Drugs Market In 2022- Growth Strategies
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)